Anandi V Law

Dr. Anandi V Law

Western University of Health Sciences

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Research in Social and Administrative Pharmacy
Verified
Journal Article
Closed access
AMAmanda R. Mercadante
Amanda R. Mercadante
ALAnandi V Law
Anandi V Law

1 July 2015 in Research in Social and Administrative Pharmacy
Verified
Journal Article
Closed access
ALAnandi V Law
Anandi V Law
PSPrashant Sakharkar
Prashant Sakharkar
AZAmir Zargarzadeh
Amir Zargarzadeh
BTBik Wai Bilvick Tai
Bik Wai Bilvick Tai
KHKarl Hess
Karl Hess
TPTony J. Park
Tony J. Park

1 August 2006 in Pediatrics
Verified
Journal Article
Closed access
PDF file
JLJennifer Le
Jennifer Le
TNThuy Nguyen
Thuy Nguyen
ALAnandi V Law
Anandi V Law
JHJane Hodding
Jane Hodding
OBJECTIVES. This study was designed to evaluate (1) the incidence and common types of adverse drug reactions among hospitalized children, (2) the frequency of adverse drug reaction reporting by health care providers, and (3) the follow-up processes resulting from adverse drug reactions.METHODS. A retrospective cohort study of pediatric patients who experienced an adverse drug reaction between January 1, 1995, and December 31, 2004, was conducted at a community-based, tertiary care, children's teaching hospital.RESULTS. A total of 1087 adverse drug reactions were reported; the overall incidence was 1.6%. The severity of most adverse drug reactions was low (levels 1–3: 89%; high levels 4–6: 11%). Adverse drug reactions with low severity were significantly more common in both the general pediatric unit and the NICU. Adverse reactions resulting from use of antibiotics (particularly penicillins, cephalosporins, and vancomycin) were usually mild. In contrast, adverse drug reactions rated high in severity were significantly more common among reactions that led to hospital admission or occurred during surgery and among certain drug classes, including anticonvulsants and antineoplastic agents. Adverse drug reactions were reported by pharmacists (89%), nurses (10%), and physicians (<1%). Although documentation of physician notification occurred for 93% of adverse drug reactions, only 29% of cases were documented in the patient's medical chart, 13% included follow-up education for individuals involved, and 10% were updated in the allergy profile of the hospital computer system.CONCLUSION. Measures to improve detection and reporting of adverse drug reactions by all health care professionals should be undertaken, to enhance our understanding of the nature and impact of these reactions in children.

1 June 2014 in American Journal of Pharmaceutical Education
Verified
Journal Article
Closed access
CJCynthia A. Jackevicius
Cynthia A. Jackevicius
JLJennifer Le
Jennifer Le
LNLama Nazer
Lama Nazer
KHKarl Hess
Karl Hess
JWJeffrey Wang
Jeffrey Wang
ALAnandi V Law
Anandi V Law
To describe the development, implementation, and evaluation of a formal mentorship program at a college of pharmacy. After extensive review of the mentorship literature within the health sciences, a formal mentorship program was developed between 2006 and 2008 to support and facilitate faculty development. The voluntary program was implemented after mentors received training, and mentors and protégés were matched and received an orientation. Evaluation consisted of conducting annual surveys and focus groups with mentors and protégés. Fifty-one mentor-protégé pairs were formed from 2009 to 2012. A large majority of the mentors (82.8%-96.9%) were satisfied with the mentorship program and its procedures. The majority of the protégés (≥70%) were satisfied with the mentorship program, mentor-protégé relationship, and program logistics. Both mentors and protégés reported that the protégés most needed guidance on time management, prioritization, and work-life balance. While there were no significant improvements in the proteges' number of grant submissions, retention rates, or success in promotion/tenure, the total number of peer-reviewed publications by junior faculty members was significantly higher after program implementation (mean of 7 per year vs 21 per year, p=0.03) in the college's pharmacy practice and administration department. A formal mentorship program was successful as measured by self-reported assessments of mentors and protégés.

1 June 2014 in American Journal of Pharmaceutical Education
Verified
Journal Article
Closed access
ALAnandi V Law
Anandi V Law
MBMichelle M. Bottenberg
Michelle M. Bottenberg
ABAnna H. Brozick
Anna H. Brozick
JCJay D. Currie
Jay D. Currie
MDMargarita V. DiVall
Margarita V. DiVall
EYElizabeth Yablonski
Elizabeth Yablonski
Mentoring of junior faculty members continues to be a widespread need in academic pharmacy in both new programs and established schools. The American Association of Colleges of Pharmacy (AACP) Joint Council Task Force on Mentoring was charged with gathering information from member colleges and schools and from the literature to determine best practices that could be shared with the academy. The task force summarized their findings regarding the needs and responsibilities for mentors and protégés at all faculty levels; what mentoring pieces are in existence, which need improvement, and which need to be created; and how effective mentoring is defined and could be measured. Based on these findings, the task force developed several recommendations as well as the PAIRS Faculty Mentorship Checklist. Academic institutions can benefit from the checklist whether they are planning to implement a faculty mentorship program or are interested in modifying existing programs.

1 July 2015 in Research in Social and Administrative Pharmacy
Verified
Journal Article
Closed access
PSPrashant Sakharkar
Prashant Sakharkar
MBMark Bounthavong
Mark Bounthavong
JHJan D. Hirsch
Jan D. Hirsch
Candis M. MorelloCandis M. Morello
Candis M. Morello
TCTimothy C. Chen
Timothy C. Chen
ALAnandi V Law
Anandi V Law